Loewen, Ondaatje, McCutcheon Starts Cardica, Inc. (CRDC) at Buy
Get Alerts CRDC Hot Sheet
Price: $2.35 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Loewen, Ondaatje, McCutcheon initiates coverage on Cardica, Inc. (NASDAQ: CRDC) with a Buy. PT $2.50.
The firm comments, "Cardica is an exciting turnaround story that will be driven by its recent commercial entry into the $1.6 billion global endoscopic stapler market. The Company’s MicroCutter XCHANGE 30 is a unique and highly differentiated surgical instrument that, among several advantages, is substantially smaller than competing products. Based on our clinician and industry due diligence, we believe Cardica is well‐positioned to capture a significant share of the 4 million minimally invasive surgeries performed annually worldwide that utilize an endoscopic stapler."
For an analyst ratings summary and ratings history on Cardica, Inc. click here. For more ratings news on Cardica, Inc. click here.
Shares of Cardica, Inc. closed at $1.07 yesterday.
The firm comments, "Cardica is an exciting turnaround story that will be driven by its recent commercial entry into the $1.6 billion global endoscopic stapler market. The Company’s MicroCutter XCHANGE 30 is a unique and highly differentiated surgical instrument that, among several advantages, is substantially smaller than competing products. Based on our clinician and industry due diligence, we believe Cardica is well‐positioned to capture a significant share of the 4 million minimally invasive surgeries performed annually worldwide that utilize an endoscopic stapler."
For an analyst ratings summary and ratings history on Cardica, Inc. click here. For more ratings news on Cardica, Inc. click here.
Shares of Cardica, Inc. closed at $1.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
- Lake Street Starts Beyond Air (XAIR) at Buy
- BofA Securities Resumes Element Solutions (ESI) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share